The New York Department of State is warning consumers to be cautious about seeking “med spa” services from unlicensed ...
Camurus today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiztm (CAM2029), octreotide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback